BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29741500)

  • 1. Immunotherapy in colorectal cancer.
    Le DT
    Clin Adv Hematol Oncol; 2018 Jan; 16(1):22-24. PubMed ID: 29741500
    [No Abstract]   [Full Text] [Related]  

  • 2. Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management.
    Overman MJ; Ernstoff MS; Morse MA
    Am Soc Clin Oncol Educ Book; 2018 May; 38():239-247. PubMed ID: 30231358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal Cancer Immunotherapy: Options and Strategies.
    Johdi NA; Sukor NF
    Front Immunol; 2020; 11():1624. PubMed ID: 33042104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed.
    Levinson K; Dorigo O; Rubin K; Moore K
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e126-e140. PubMed ID: 31099679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence?
    Colombo MP
    Clin Cancer Res; 2017 Oct; 23(20):5999-6001. PubMed ID: 29030331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens.
    Moradi A; Pourseif MM; Jafari B; Parvizpour S; Omidi Y
    Pharmacol Res; 2020 Jun; 156():104790. PubMed ID: 32278043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Have We Got to Lose?
    McNeil CM
    J Clin Oncol; 2016 Dec; 34(36):4443-4444. PubMed ID: 27998220
    [No Abstract]   [Full Text] [Related]  

  • 8. Calling time on the immunotherapy gold rush.
    The Lancet Oncology
    Lancet Oncol; 2017 Aug; 18(8):981. PubMed ID: 28759366
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes.
    Chau I
    Clin Cancer Res; 2017 Oct; 23(20):6002-6011. PubMed ID: 28615369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing immunotherapy for colorectal cancer.
    Ganesh K
    Nat Rev Gastroenterol Hepatol; 2022 Feb; 19(2):93-94. PubMed ID: 34907331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetuzumab govitecan in metastatic colorectal cancer.
    Das M
    Lancet Oncol; 2017 Oct; 18(10):e563. PubMed ID: 28844817
    [No Abstract]   [Full Text] [Related]  

  • 13. Combinatorial immunotherapy for melanoma.
    George DD; Armenio VA; Katz SC
    Cancer Gene Ther; 2017 Mar; 24(3):141-147. PubMed ID: 27834353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoantigens in the immuno-oncology space.
    Arlen PM
    Future Oncol; 2017 Oct; 13(25):2209-2211. PubMed ID: 28976211
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy in Older Adults: A Checkpoint to Palliation?
    Elias R; Odejide O
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e110-e120. PubMed ID: 31099630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of colorectal cancer: new perspectives after a long path.
    Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
    Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are targeted agents the key to unlock the code for immune checkpoint inhibitors in soft-tissue sarcomas?
    Assi T
    Future Oncol; 2019 Oct; 15(28):3185-3187. PubMed ID: 31578878
    [No Abstract]   [Full Text] [Related]  

  • 18. The interest of sequential treatment with immune check point inhibitors followed chemotherapy: A case report.
    Lasserre M; Domblides C; Gross-Goupil M; Ravaud A; Daste A
    Oral Oncol; 2019 Jul; 94():125-127. PubMed ID: 31078371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Improving efficacy of cancer immunotherapy through targeting of macrophages].
    Peranzoni E; Donnadieu E
    Med Sci (Paris); 2019 Mar; 35(3):207-209. PubMed ID: 30931902
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.
    Singh P; Toom S; Huang Y
    J Hematol Oncol; 2017 May; 10(1):105. PubMed ID: 28494772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.